Tilray is strategically positioned to benefit from U.S. cannabis reform, leveraging its diversified international and U.S.

TLRY remains a Hold, despite the double digits international growth prospects and the potential synergy from its vertically ...

Detailed price information for Tilray Brands Inc (TLRY-Q) from The Globe and Mail including charting and trades.

Detailed price information for Tilray Brands Inc (TLRY-Q) from The Globe and Mail including charting and trades.

Tilray Medical, a division of Tilray Brands, recently rebranded its Italian unit as Tilray Medical Italia and expanded its EU-GMP certified medical cannabis portfolio, including multiple flower and ...

Tilray Medical, a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering ...

SweetWater Brewing Company ("SweetWater Brewing" or "SweetWater"), the leading craft beer brand in the Southeast by Tilray ...

Tilray's fiscal second-quarter revenue of $217.5 million was a record high. Its cannabis business generated growth, but its ...

TLRY posts a standout international quarter as cannabis revenues jump 36% year over year, driving supply shifts and broader ...

So far, the company has been unable to do so and has partly relied on acquisitions during the past five years to increase its ...

Tilray Brands TLRY delivered net revenues of $217.5 million in the second quarter of fiscal 2026, a quarterly record driven ...